Drugs and Devices

FDA approves new drug for psoriasis

On January 21, the U.S. Food and Drug Administration (FDA) approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares